BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 22037318)

  • 1. Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer.
    Kalogera E; Scholler N; Powless C; Weaver A; Drapkin R; Li J; Jiang SW; Podratz K; Urban N; Dowdy SC
    Gynecol Oncol; 2012 Feb; 124(2):270-5. PubMed ID: 22037318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Serum HE4 with Primary Tumor Diameter and Depth of Myometrial Invasion in Endometrial Cancer Patients at Rajavithi Hospital.
    Prueksaritanond N; Cheanpracha P; Yanaranop M
    Asian Pac J Cancer Prev; 2016; 17(3):1489-92. PubMed ID: 27039795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET).
    Antonsen SL; Høgdall E; Christensen IJ; Lydolph M; Tabor A; Loft Jakobsen A; Fagö-Olsen CL; Andersen ES; Jochumsen K; Høgdall C
    Acta Obstet Gynecol Scand; 2013 Nov; 92(11):1313-22. PubMed ID: 24032654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of serum HE4 level in the management of endometrial cancer: A pilot study.
    Rajadevan N; McNally O; Neesham D; Richards A; Naaman Y
    Aust N Z J Obstet Gynaecol; 2021 Apr; 61(2):284-289. PubMed ID: 33528032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CA125 and HE4 levels in a Czech female population diagnosed with endometrial cancer in preoperative management.
    Presl J; Novotny Z; Topolcan O; Vlasak P; Kucera R; Fuchsova R; Vrzalova J; Betincova L; Svobodova S
    Anticancer Res; 2014 Jan; 34(1):327-31. PubMed ID: 24403483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of circulating tumour cells may add value in endometrial cancer management.
    Ni T; Sun X; Shan B; Wang J; Liu Y; Gu SL; Wang YD
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():1-4. PubMed ID: 27756035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HE4 and CA125 as preoperative risk stratifiers for lymph node metastasis in endometrioid carcinoma of the endometrium: A retrospective study in a cohort with histological proof of lymph node status.
    O'Toole SA; Huang Y; Norris L; Power Foley M; Shireen R; McDonald S; Kamran W; Ibrahim N; Ward M; Thompson C; Murphy C; D'Arcy T; Farah N; Heron E; O'Leary JJ; Abu Saadeh F; Gleeson N
    Gynecol Oncol; 2021 Feb; 160(2):514-519. PubMed ID: 33213897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative Serum Human Epididymis Protein 4 Levels in Early Stage Endometrial Cancer: A Prospective Study.
    Fanfani F; Restaino S; Cicogna S; Petrillo M; Montico M; Perrone E; Radillo O; De Leo R; Ceccarello M; Scambia G; Ricci G
    Int J Gynecol Cancer; 2017 Jul; 27(6):1200-1205. PubMed ID: 28557834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum HE4 as a prognostic marker in endometrial cancer--a population based study.
    Brennan DJ; Hackethal A; Metcalf AM; Coward J; Ferguson K; Oehler MK; Quinn MA; Janda M; Leung Y; Freemantle M; ; Webb PM; Spurdle AB; Obermair A
    Gynecol Oncol; 2014 Jan; 132(1):159-65. PubMed ID: 24211402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HE4 is superior to CA125 in the detection of recurrent disease in high-risk endometrial cancer patients.
    Abbink K; Zusterzeel PL; Geurts-Moespot AJ; Herwaarden AEV; Pijnenborg JM; Sweep FC; Massuger LF
    Tumour Biol; 2018 Feb; 40(2):1010428318757103. PubMed ID: 29463191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Value of Preoperative CA 125 Levels in Prediction of Myometrial Invasion in Patients with Early-stage Endometrioid- type Endometrial Cancer.
    Atguden Z; Yildiz A; Aksut H; Yalcin SE; Yalcin Y; Uysal D; Yetimalar H
    Asian Pac J Cancer Prev; 2016; 17(2):497-501. PubMed ID: 26925634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of HE4 and CA125 in differentiation between malignant and non-malignant endometrial pathologies.
    Abdalla N; Pazura M; Słomka A; Piórkowski R; Sawicki W; Cendrowski K
    Ginekol Pol; 2016; 87(12):781-786. PubMed ID: 28098927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of tumor marker HE4 as prognostic factor in endometrial cancer: a single-center controlled study.
    Capriglione S; Plotti F; Miranda A; Ricciardi R; Scaletta G; Aloisi A; Guzzo F; Montera R; Angioli R
    Tumour Biol; 2015 Jun; 36(6):4151-6. PubMed ID: 25577252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of HE4 to identify patients with endometrioid endometrial cancer who may require lymphadenectomy.
    Dobrzycka B; Mackowiak-Matejczyk B; Terlikowska KM; Kinalski M; Terlikowski SJ
    Adv Med Sci; 2016 Mar; 61(1):23-7. PubMed ID: 26344910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of preoperative HE4 as predictor of advanced disease in endometrioid endometrial cancer.
    Espiau Romera A; Coronado Martín PJ; Chóliz Ezquerro M; Cuesta Guardiola T; Adiego Calvo I; Baquedano Mainar L
    Int J Gynaecol Obstet; 2021 Apr; 153(1):64-70. PubMed ID: 33156532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum HE4 and CA125 combined to predict and monitor recurrence of type II endometrial carcinoma.
    Quan Q; Liao Q; Yin W; Zhou S; Gong S; Mu X
    Sci Rep; 2021 Nov; 11(1):21694. PubMed ID: 34737393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of human epididymis protein 4 in endometrial cancer and its utility for surgical staging.
    Minar L; Klabenesova I; Jandakova E; Zlamal F; Bienertova-Vasku J
    J Obstet Gynaecol Res; 2015 Oct; 41(10):1644-52. PubMed ID: 26223178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum HE4 is correlated to prognostic factors and survival in patients with endometrial cancer.
    Stiekema A; Lok C; Korse CM; van Driel WJ; van der Noort V; Kenter GG; Van de Vijver KK
    Virchows Arch; 2017 Jun; 470(6):655-664. PubMed ID: 28401338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance.
    Brennan DJ; Hackethal A; Mann KP; Mutz-Dehbalaie I; Fiegl H; Marth C; Obermair A
    BMC Cancer; 2015 Feb; 15():33. PubMed ID: 25655024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus.
    Moore RG; Brown AK; Miller MC; Badgwell D; Lu Z; Allard WJ; Granai CO; Bast RC; Lu K
    Gynecol Oncol; 2008 Aug; 110(2):196-201. PubMed ID: 18495222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.